Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019-2020.

Ejezie, Chinenye Lynette; Osaghae, Ikponmwosa; Ayieko, Sylvia; Cuccaro, Paula

Ejezie, Chinenye Lynette; Osaghae, Ikponmwosa; Ayieko, Sylvia; Cuccaro, Paula.

Afiliación

Ejezie CL; Department of Health Promotion and Behavioral Sciences, The University of Texas School of Public Health, 1200 Pressler St, Houston, TX 77030, USA.
Osaghae I; Department of Investigational Cancer Therapeutics, The University of MD Anderson Cancer Center, Houston, TX 77030, USA.
Ayieko S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cuccaro P; Department of Epidemiology, Human Genetics & Environmental Sciences, The University of Texas School of Public Health, Houston, TX 77030, USA.

Vaccines (Basel) ; 10(4)2022 Apr 08.

Article en En | MEDLINE | ID: mdl-35455325

Palabras clave

9-valent; HPV vaccination; dosing interval; dosing schedule; low adherence

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google